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A B S T R A C T
Direct international comparisons which aim to understand how factors associated with human papillomavirus
(HPV) vaccine initiation and attitudes towards the HPV vaccination in parents diﬀer are scarce. Parents
(n= 179) of daughters aged 9–17 years in the US, UK and Australia completed an online survey in 2011 with
questions measuring daughters' HPV vaccination status, HPV knowledge, HPV vaccination knowledge, and
statements assessing attitude towards the HPV vaccine. The strongest factor associated with vaccination status
across all countries was parental HPV knowledge (p < 0.001). Parents with both very low and very high
knowledge scores were less likely to have vaccinated their daughters. Parents with higher HPV vaccination
knowledge scores intended to vaccinate their daughters (if not already vaccinated) for protective reasons
(p < 0.001), while those whose daughters were already vaccinated understood that vaccination protection was
not 100% and that their daughters may still be at risk of getting HPV (p < 0.05). Compared to the UK and
Australia, a higher proportion of parents with unvaccinated daughters from the US were worried about the side-
eﬀects of the HPV vaccination (US: 60.5%, UK: 36.4%, AUS: 15.4%; p < 0.05), believed that getting the vac-
cination might be a hassle (US: 21.1%, UK: 0%, AUS: 7.7%; p < 0.05), and that the vaccine was too new (US:
44.7%, UK: 22.7%, AUS: 7.7%; p < 0.05). This study adds to the understanding of how parents may inﬂuence
vaccination uptake by demonstrating the eﬀect of knowledge and the parental attitudes towards HPV vacci-
nation across three countries.
1. Introduction
High-risk types of human papillomavirus (HPV), the most common
sexually transmitted infection (STI) internationally, can lead to devel-
opment of cervical cancer as well as genital warts, anal, penile and
oropharyngeal cancers (Forman et al., 2012). In 2006, the United States
Food and Drug Administration (FDA) approved the quadrivalent vac-
cine for the prevention of HPV types 6, 11, 16 and 18 (U.S. Food and
Drug Administration, 2006) associated with over of 70% of all cervical
cancer cases and 90% of genital warts cases (Munoz et al., 2004). In
2008, the FDA further approved the bivalent HPV vaccination which
prevents HPV types 16 and 18 protecting against cervical cancer but not
strains of HPV that cause genital warts (U.S. Food and Drug
Administration, 2006, 2009a). Recently, a nonavalent vaccine has been
licensed for use in the European Union and the United States (US),
providing protection against ﬁve additional high-risk types of HPV
(Forster &Waller, 2016). Widespread use of this vaccine has not yet
begun in the United Kingdom (UK), however, it is currently the only
vaccine being administered in the US. Now, almost all high-income
countries have one of the HPV vaccines available to girls and young
women, although the choice of vaccine, the cohorts it is oﬀered to, the
way it is administered and the cost, varies. In the US, the HPV vaccine is
predominantly available through physicians' clinics and medical cen-
tres, while in the UK and Australia, publically funded school-based
programs oﬀer the vaccine free to girls age 12–13. In 2007, Australia
was the ﬁrst country internationally to launch publically funded school-
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based programs, with the UK launching their program a year later in
2008. Australia also had catch-up programs targeting young women in
schools and the community, and the UK had a similar catch-up program
from 2008 to 2010.
Given that the primary target population for HPV vaccination pro-
grams is girls aged 9–13 years, typically before the initiation of sexual
activity (World Health Organisation, 2013), parental knowledge and
attitudes play an important role in the success of vaccination as consent
is usually required for their adolescent children to be vaccinated. Re-
search aimed at understanding HPV vaccine uptake has demonstrated
that uptake of the HPV vaccine is generally high, however parents and
girls often have insuﬃcient knowledge and understanding about and
have varying attitudes towards vaccination (Hendry et al., 2013).
Alongside this, several studies conducted across diﬀerent settings have
aimed to examine factors inﬂuencing HPV vaccine uptake. Findings
from these studies are wide-ranging, however, parental intentions have
been shown to consistently be a strong predictor of their children's HPV
vaccine uptake (Alberts et al., 2017; Mupandawana & Cross, 2016).
The understanding of parental psychosocial determinants that in-
ﬂuence HPV vaccine initiation is a growing area of research (Allen
et al., 2010; Krawczyk et al., 2015a; Krawczyk et al., 2015b; Trim et al.,
2012), although no studies have directly compared countries that use
diﬀerent methods of administering the vaccine, such as school-based or
non-school-based programs. Using online survey data collected across
three countries, this study examined parents of 9–17 year-old girls in
the US, UK and Australia to identify country-speciﬁc factors which are
associated with their daughters' vaccination status (HPV vaccine in-
itiation). It also compared attitude diﬀerences between countries and
by HPV vaccination knowledge by using identical knowledge and at-
titude variables in order to help better identify how parents' attitudes
and knowledge play a role in vaccination participation internationally.
2. Material and methods
2.1. Participants
Participants (n= 12,259) from the US, UK and Australia were di-
rected to a web-based survey by Survey Sampling International (SSI).
SSI has existing online panels of participants who sign up to take part in
market research for points which go towards a small reward (e.g.
coupons and discounts). Quotas were set to ensure adequate re-
presentation of diﬀerent age-groups and genders. The initial target
sample for the survey was 2400 participants aged 18–70 years with
approximately 800 participants from each country, including an equal
number of men and women. Participants meeting these criteria were
recruited to the survey. Participants were asked additional demo-
graphic questions including whether they had a daughter aged
9–17 years of age (the HPV vaccination age-range). From this in-
formation, survey data was analysed from participants who indicated
they had at least one daughter in the HPV vaccination age-range.
Ethical approval was obtained from human research ethics committees
at Indiana University, USA, University College London, UK and the
University of Sydney, Australia.
2.2. Measures
Participants were given information which included the purpose of
the study, conﬁdentiality and anonymity information and contact de-
tails for researchers in their country. Initially participants were asked
their age, gender and country of residence to determine if they were
eligible to take part in the survey, based on the quota of n= 400 men
and n= 400 women from each country. Before participants began the
questions on HPV knowledge they were asked ‘how many daughters do
you have between the ages of 9 and 17’. If participants had a daughter
or daughters in this age-range they were asked for their daughters'
speciﬁc age(s) and how many of those had received at least one dose of
the HPV vaccine. If at least one of the participant's daughters had been
vaccinated, the parent was classiﬁed as “vaccinated” for the outcome
variable. All participants were then asked questions on their knowledge
of HPV (16 questions) and HPV vaccination (7 questions), which were
later validated (Waller et al., 2013). Response options for the two sets
of knowledge questions were True/False/Don't know, and data on
knowledge of HPV, HPV vaccination and HPV testing were analysed
and results published (Dodd et al., 2014; Marlow et al., 2013).
If participants answered that they had a daughter in the vaccination
age-range they were further directed to a set of purposely designed
attitude statements on HPV and HPV vaccination (Supplementary
Table 1) which were derived from a UK survey (Marlow et al., 2007).
Statements were directed speciﬁcally to either participants with at least
one unvaccinated daughter eligible for HPV vaccination (14 attitude
statements) or participants with at least one daughter who had received
one or more doses of vaccine (8 attitude statements), with both sets of
parents receiving the same eight attitude statements (with the wording
only diﬀering slightly based on context). Parents with at least one un-
vaccinated daughter were given an additional six attitude statements.
Response options for the attitude statements were given as a 5-point
Likert scale (Strongly disagree, Disagree, Neither disagree nor agree,
Agree, Strongly agree). Data analysis on attitudes to HPV and to HPV
vaccination was performed on the responses of participants who in-
dicated that they had a daughter who was of vaccination age.
Participants were removed from the ﬁnal analysis if they did not
know whether their daughter had received the HPV vaccination, if they
had never heard of the HPV vaccination or if they did not answer any of
the parental attitude statements on HPV or the HPV vaccination
(n= 146).
2.3. Statistical analysis
Responses to attitude items were collapsed into three categories:
Disagree (Strongly disagree and Disagree), Neither disagree nor agree,
and Agree (Agree and Strongly agree). Parental HPV vaccination
knowledge scores (ranging from 0 to 7) were combined into three ca-
tegories: low (0–2 correct responses), medium (3–4), and high (5+).
Chi-square tests were conducted initially to investigate the association
between knowledge, attitudes and daughters' vaccination status.
The association between the proportion with daughters “not vacci-
nated” and the demographic, knowledge (as a continuous measure) and
attitude variables were investigated using logistic regression with odds
ratios reported from these models. Initially all variables were ﬁtted
univariately with the outcome and then a multivariable model was
constructed. We decided a priori on the most important variables to be
included in the model and included all the attitude variables regardless
of signiﬁcance because of the small sample size. For the model building,
all demographic factors were ﬁtted and then backwards elimination
applied. The knowledge measures were then included and backwards
elimination used. Finally, all attitude variables were added to produce
the ﬁnal model. The attitude regarding genital warts was only measured
in two countries so it was ﬁtted separately where the data was available
and adjusted for all factors in the ﬁnal model. This is because at the
time of data collection the US and Australia oﬀered Gardasil which
protects against genital warts and the UK oﬀered Cervarix which did
not protect against genital warts. Fractional polynomials were used to
assess the linearity of the association between the continuous knowl-
edge scores and vaccination status. Likelihood ratio p-values were used
to assess statistical signiﬁcance with p < 0.05 considered signiﬁcant.
Data were analysed using SPSS V.21 (IBM, Armonk, NY). The lo-
gistic regression models were conducted in Stata 14 (StataCorp. 2015.
Stata Statistical Software: Release 14. College Station).
3. Results
The survey had a 62% response rate, as a total of 12,259 men and
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women were directed to the HPV survey, 3959 were deemed eligible
and invited to take part, and 2442 participants completed the survey.
From that sample, 325 participants identiﬁed themselves as parents of
daughters aged 9–17 years. Parents who did not know their daughters'
vaccination status, had never heard of HPV or did not answer any
questions or attitude statements were excluded, leaving 179 parents in
the analysed sample (Fig. 1). Participant characteristics are shown in
Table 1. Overall, 59.2% of parents reported that their daughter had
received the HPV vaccine.
3.1. Factors associated with non-vaccinated status across the entire sample
The strongest factor associated with daughters' vaccination status
across the entire sample was parents' HPV knowledge (p < 0.001;
Table 2). As shown in Fig. 2, parents' HPV knowledge scores displayed a
non-linear relationship; parents with low knowledge scores and parents
with high knowledge scores were less likely to have vaccinated their
daughters. HPV vaccination speciﬁc knowledge was also a signiﬁcant
univariate factors associated with of vaccination status (p < 0.05) and
displayed a non-linear relationship; parents with lower levels of vac-
cination speciﬁc knowledge and very high levels of vaccination speciﬁc
knowledge were also less likely to have vaccinated their daughters.
Parents' demographic characteristics including their country of origin
(OR = 2.204, 95% CI 1.07–4.50; p < 0.05) and gender (OR = 0.492
95% CI [0.259, 0.935], p < 0.05) were also factors associated with
non-vaccination in our sample, with parents in the US and men (across
all countries) being less likely to vaccinate their daughters.
3.2. Parental attitude diﬀerences by country
As shown in Table 3 (and in Supplementary Table 2), among parents
with unvaccinated daughters, worry about the side-eﬀects of the vac-
cine was signiﬁcantly more prevalent in the US than the UK or Australia
(US 60.5% agree, UK 36.4%, AUS 15.4%, p < 0.05). Non-vaccinating
parents from the US were also more likely to agree that getting all 3
doses of the HPV vaccine would be a big hassle (US 21.1% agree, UK
0%, AUS 7.7%, p < 0.05) and that the HPV vaccine is so new that they
would want to wait before deciding to get it for their daughter (US
44.7% agree, UK 22.7%, AUS 7.7%, p < 0.05).
Parents with vaccinated daughters from the US were more likely
than their Australian counterparts to agree that genital warts are not
something they worry about for their daughters now that they are
vaccinated (US 41.4%, AUS 15.0%, p < 0.05). UK parents were not
given this question.
3.3. Association between HPV vaccination knowledge and parental attitudes
The signiﬁcant associations between parental attitudes and HPV
vaccination knowledge are presented in Table 4 (and in Supplementary
Table 3). Compared to parents of unvaccinated daughters with low
knowledge scores, those with higher knowledge scores were more likely
to believe that they want to be on the safe side and vaccinate their
daughters (low knowledge = 27.3%, medium = 44.1%,
high = 74.1%; p≤0.001). Compared to parents of vaccinated daugh-
ters with low knowledge scores, those with higher knowledge scores
believed that their daughters may still one day be at risk of getting HPV
(low knowledge = 22.2% vs medium = 61.7% vs high = 62.0%;
p < 0.05) and that it is still possible for their daughters to get HPV in
Fig. 1. Participant recruitment.
⁎Participants outside the age range 18–70 years.
⁎⁎Data involved inconsistencies therefore survey may not
have been completed properly.
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the future (low knowledge = 11.1% vs medium = 53.2% vs
high = 62.0%; p < 0.05).
4. Discussion
Our study contributes to the literature by providing an international
comparison of correlates of HPV vaccination uptake using identical
knowledge and attitude variables across three countries. It found that
shortly after introduction of the HPV vaccine, HPV knowledge level was
associated with vaccination uptake, and parental attitudes diﬀered by
both country and level of HPV vaccination knowledge.
Across all three countries (US, UK and Australia), parents were more
likely to have chosen not to vaccinate their daughters if they scored
very low or very high on HPV knowledge and HPV vaccination speciﬁc
knowledge questions. Parents of unvaccinated daughters with higher
vaccination knowledge scores in our sample did, however, express at-
titudes favouring vaccinating their daughters in the future. Evidence
varies across a number of countries and settings as to whether knowl-
edge impacts vaccination uptake. Some studies report a correlation
between higher levels of parental HPV knowledge and vaccine ac-
ceptability (de Visser &McDonnell, 2008; Woodhall et al., 2007), and
others reporting no correlation (Allen et al., 2010; Dempsey et al.,
2006; Fishman et al., 2014; Hausdorf et al., 2007; Lenselink et al.,
2008). We also found that country of origin and gender were associated
with HPV vaccine initiation with parents residing in the US and males
in all three countries being less likely to have daughters who were
vaccinated (where vaccination is not part of a school-based program).
In regards to parental attitudes, we found that parents of
unvaccinated daughters in the US were more worried about the side
eﬀects of the HPV vaccine than parents of unvaccinated girls in the UK
and Australia. This supports the ﬁnding from this study that more
parents with daughters in the vaccination age-range from the US in our
sample compared to the UK and Australia were not vaccinated.
Previous studies have shown that parents in the US express serious
concerns about vaccines for their children. A study conducted in the US
with 1552 parents found that more than half (54%) still worry about
vaccine side eﬀects (Freed et al., 2010), and overall, 11.5% of parents
had refused at least one vaccine their doctor had recommended, with
the HPV vaccine being the most commonly refused (56%). Further-
more, a recent systematic review on barriers to the HPV vaccination in
the US found that parental attitudes to the vaccine included the need for
parents in the US to receive more information before vaccinating their
child, and concerns about adverse eﬀects of the vaccine (Holman et al.,
2014). Parents from the US with unvaccinated daughters more often
believed that getting all three doses of the HPV vaccine would be a
signiﬁcant obstacle, not surprisingly as the HPV vaccine distribution in
the US is predominantly available through physicians' clinics and
medical centres, whereas in the UK and Australia free school-based and
catch-up programs are oﬀered (Wong et al., 2011). Parents of un-
vaccinated daughters from the US also believed that the vaccine was so
new that they would want to wait before deciding to get it for their
daughter. This ﬁnding was unexpected given that advertising about
HPV contributed to an increased awareness of HPV in the US at the time
of data collection (Cates et al., 2010; Hughes et al., 2009). It is im-
portant to note however, that this survey was conducted in 2011, and
therefore attitudes of US parents now may diﬀer.
Parental vaccination knowledge was also shown to be associated
with attitudes towards the HPV vaccine. Our study found that parents of
unvaccinated daughters with higher vaccination knowledge scores ex-
pressed attitudes that they intended to vaccinate their daughters, and
be on the safe side. This ﬁnding might help explain why many of the
parents with higher HPV knowledge and HPV vaccine knowledge scores
in our sample had daughters who had not yet been vaccinated. For
parents of vaccinated daughters with higher knowledge scores, they
understood that although they have vaccinated their daughters they
may still be at risk of getting HPV in the future. This demonstrates that
vaccinated parents in our study with higher HPV vaccination knowl-
edge had better understanding of the risks of HPV.
By recruiting parents online through a wider survey, this study was
able to directly compare parental attitudes across three countries, al-
though recruitment using online panel samples and the use of quotas to
ensure adequate representation of diﬀerent age-groups and genders
means that the sample may not be representative of parents in the US,
UK and Australia. The use of quotas did, however, ensure that re-
spondents with lower levels of education were well represented as
shown with our sample. Furthermore, using a survey design allowed us
to be able to separate parents who had vaccinated and unvaccinated
daughters in our analysis to determine factors associated with vacci-
nation status and compare attitudinal diﬀerences within the groups, as
survey questions were tailored to parents based on their daughters'
vaccination status.
Our study was limited by the relatively small proportion of re-
spondents who identiﬁed as parents of daughters aged 9–17 years.
Having a larger group of parents included in the study may have pro-
vided more signiﬁcant results, as many of our attitudinal results were
approaching signiﬁcance. However, importantly, we included both
women and men in our sample. Previous studies on HPV parental at-
titudes have mainly focused on mothers, although with the HPV vac-
cination now provided to school-aged boys (U.S. Food and Drug
Administration, 2009b), fathers' knowledge and attitudes may be in-
creasingly important.
Furthermore, our study focused on intrapersonal factors that may be
associated with HPV vaccine initiation. Healthcare provider (HCP) re-
commendations, along with various interpersonal and environmental
Table 1
Participant characteristics (n= 179).
Characteristic USA
(n= 67)
UK (n= 59) Australia
(n= 53)
Age [mean (SD)] 37.8 (9.97) 39.4 (8.72) 42.5 (8.92)
Gender [n (%)]
Men 21 (31.3) 21 (35.6) 24 (45.3)
Women 46 (68.7) 38 (64.4) 29 (54.7)
Daughter's vaccination status [n
(%)]
Vaccinated 29 (43.3) 37 (62.7) 40 (75.5)
Not vaccinated 38 (56.7) 22 (37.3) 13 (24.5)
Ethnicitya [n (%)]
Majority 50 (74.6) 50 (84.7) 42 (79.2)
Minority 17 (25.4) 9 (15.3) 11 (20.8)
Educationb [n (%)]
High 49 (73.1) 29 (49.2) 19 (35.8)
Low 18 (26.9) 30 (50.8) 34 (64.2)
Relationship status [n (%)]
Married/partner 49 (73.1) 46 (78.0) 43 (81.1)
Dating/single 18 (26.9) 13 (22.0) 10 (18.9)
Religious engagement [n (%)]
Often 34 (50.7) 13 (22.0) 12 (22.6)
Sometimes 20 (29.9) 8 (13.6) 7 (13.2)
Rarely or never 13 (19.4) 38 (64.4) 34 (64.2)
Average HPV knowledge score
[mean (SD)]c
9.75 (4.02) 9.25 (3.43) 9.47 (2.99)
Average HPV vaccination
knowledge score [mean
(SD)]d
4.18 (1.72) 4.10 (1.64) 4.34 (1.07)
a Majority in USA = white non-Hispanic, UK = white British, AUS = white
Australian.
b Education was coded as follows: High: college graduate/graduate school, some col-
lege/associate degree (USA), degree/post-graduate degree, vocational/A-levels/other
qualiﬁcation < degree (UK), any university education, vocational qualiﬁcation (AUS);
Low: high school, CED or below (USA), no formal education/GCSEs (UK), no formal
education/high school (AUS).
c HPV knowledge scores ranged from 0 to 16 and was measured on the number of
correct answers out of 16 questions.
d HPV vaccination knowledge score ranged from 0 to 7 and was measured on the
number of correct answers out of 7.
B. Nickel et al. Preventive Medicine Reports 8 (2017) 169–176
172
Table 2
Factors associated with non-vaccination of daughters (9–17 years) with HPV vaccine (n= 179).
Factors Agreement No. of parents Univariate model Multivariate model
Adjusted OR (95%
CI)
p-Value Adjusted OR (95%
CI)
p-Value
Demographics
Age – 179 1.000 (0.969, 1.032) 0.9892
Gender 0.0278
Male – 66 0.492 (0.259,
0.935)⁎
Female (ref) 113 1
Country 0.0012 0.1039
USA 67 2.204 (1.077,
4.507)⁎
1.337 (0.567, 3.154)
Australia – 53 0.547 (0.241, 1.239) 0.496 (0.191, 1.288)
UK (ref) 59 1 1
Qualiﬁcations 0.0958
High school grad or below – 82 0.599 (0.327, 1.099)
Uni/college or above (ref) 97 1
Ethnicity 0.7329
Other – 37 1.136 (0.547, 2.362)
White (ref) 142 1
Relationship 0.5317
Single/dating – 41 0.796 (0.387, 1.634)
Partner/married (ref) 138 1
Religious services attendance 0.5291
Sometimes – 35 1.467 (0.660, 3.259)
Often 59 1.372 (0.697, 2.703)
Rarely or never (ref) 85 1
Knowledge
HPV knowledge – 179 < 0.001 < 0.001
Linear term 0.454 (0.296,
0.695)⁎⁎
0.431 (0.259,
0.716)⁎⁎
Square term 1.051 (1.026,
1.077)⁎⁎
1.055 (1.026,
1.086)⁎⁎
HPV vaccination knowledge – 179 0.0042
Linear term 2.813 (0.585,
13.515)
Square term 0.561 (0.331,
0.950)⁎
Cube term 1.067 (1.015,
1.122)⁎
Attitudesa
Having the HPV vaccination might make girls more like to have
sex
Disagree (ref) 111 1 0.4775 1 0.3674
Neither agree nor
disagree
42 1.167 (0.571, 2.387) 1.144 (0.366, 3.576)
Agree 26 0.628 (0.252, 1.567) 0.417 (0.096, 1.812)
Girls who have the HPV vaccination might be more likely to
have unprotected sex
Disagree (ref) 84 1 0.8785 1 0.7052
Neither agree nor
disagree
63 1.103 (0.569, 2.139) 0.907 (0.332, 2.481)
Agree 32 0.882 (0.382, 2.039) 1.578 (0.375, 6.636)
Cervical cancer is not something I worry about for my daughter Disagree (ref) 88 1 0.626 1 0.9925
Neither agree nor
disagree
55 0.776 (0.390, 1.543) 0.964 (0.415, 2.240)
Agree 36 0.710 (0.319, 1.580) 0.938 (0.310, 2.839)
My daughter may one day be at risk of getting HPV Disagree (ref) 18 1 0.0951 1 0.0992
Neither agree nor
disagree
47 0.478 (0.155, 1.477) 0.912 (0.168, 4.965)
Agree 114 1.048 (0.386, 2.850) 2.454 (0.582,
10.357)
I am very worried about the side eﬀects of the HPV vaccination
for my daughter
Disagree (ref) 52 1 0.1221 1 0.1406
Neither agree nor
disagree
60 1.500 (0.685, 3.283) 2.503 (0.915, 6.848)
Agree 67 2.184 (1.022, 4.665) 2.245 (0.833, 6.055)
It is like that my daughter will get HPV one day Disagree (ref) 61 1 0.9657 1 0.504
Neither agree nor
disagree
92 1.013 (0.525, 1.956) 1.227 (0.509, 2.959)
Agree 26 0.900 (0.351, 2.305) 0.627 (0.180, 2.181)
It is possible that my daughter may get HPV in the future Disagree (ref) 16 1 0.0502 1 0.104
Neither agree nor
disagree
68 0.248 (0.077, 0.797) 0.175 (0.030, 1.013)
Agree 95 0.303 (0.097, 0.942) 0.191 (0.036, 1.000)
(continued on next page)
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inﬂuences have also been shown to be associated with initiation and are
important to understand. As demonstrated across several studies (Ferrer
et al., 2014; Gamble et al., 2010; Mohammed et al., 2017; Staras et al.,
2014; Stephens et al., 2016), HCPs' inﬂuence on vaccine uptake appears
to often outweigh parental knowledge and attitudes.
Since acceptance of HPV vaccination varies internationally, and
many adolescents are still not getting the HPV vaccine in various
countries (Wigle et al., 2016), it is important to understand why some
parents choose to vaccinate their children and some parents do not in
order to continue to increase vaccination uptake. Importantly, our
study focuses on parental factors associated with the HPV vaccination
across three countries following vaccination introduction and adds to
the growing body of existing research which explores how parents'
knowledge and attitudes may inﬂuence vaccine uptake. This is the ﬁrst
study to directly assess parental knowledge and attitudes across dif-
ferent countries and between school based and non-school based pro-
grams. This understanding is important in order to target interventions
aimed at improving knowledge and changing attitudes which, in turn,
may help increase vaccination participation internationally and in the
individual countries included in this study. In particular, US-based re-
search has shown HCPs to be inﬂuential over parental decisions about
the HPV vaccine, and this study has identiﬁed areas which could be
useful to focus discussions with parents about their child receiving the
HPV vaccine. Furthermore, the UK and Australia have universal health
care systems with vaccination policy determined centrally, whereas in
the US vaccination policy is determined on a far less coherent state-to-
state basis and may therefore allow parental attitudes to be particularly
Table 2 (continued)
Factors Agreement No. of parents Univariate model Multivariate model
Adjusted OR (95%
CI)
p-Value Adjusted OR (95%
CI)
p-Value
Genital warts are not something I worry about for my daughterb Disagree (ref) 55 1 0.0913 1 0.105c
Neither agree nor
disagree
41 0.683 (0.302, 1.544) 0.674 (0.187, 2.421)
Agree 24 0.321 (0.111, 0.932) 0.185 (0.036,
0.941)⁎
a 8 attitude statements that were given to both groups of parents.
b Participants from the UK were not given this question, therefore 59 participants missing.
c Estimated in the USA and AUS only in a separate model adjusting for all other variables from the multivariable model.
⁎ p < 0.05.
⁎⁎ p < 0.01.
Fig. 2. Estimated proportion of daughters not vaccinated as a quadratic function of
parents' HPV knowledge.
Table 3
Signiﬁcant parental attitude diﬀerences by country.
Unvaccinated daughters (n= 73) Vaccinated daughters (n= 106)
Attitudes Country Agreement (%)a p-Valueb Attitudes Country Agreement (%)a p-Valueb
Disagree Neither
agree nor
disagree
Agree Disagree Neither
agree nor
disagree
Agree
I would be very worried about
the side eﬀects of the HPV
vaccination for my daughter
USA 13.2 26.3 60.5 0.029 Now that my daughter has been
vaccinated, genital warts are
not something I worry about for
her
USA 37.9 20.7 41.4 0.025
UK 22.7 40.9 36.4 UKc – – –
AUS 46.2 38.5 15.4 AUS 40.0 45.0 15.0
Getting my daughter all 3 doses
of the HPV vaccine would
be a big hassle
USA 57.9 21.1 21.1 0.042
UK 54.5 45.5 0.0
AUS 76.9 15.4 7.7
The HPV vaccine is so new that I
want to wait before
deciding to get it for my
daughter
USA 26.3 28.9 44.7 0.014
UK 40.9 36.4 22.7
AUS 76.9 15.4 7.7
a Row percentages for comparison across countries.
b Pearson chi-square test used.
c Participants from the UK were not given this question.
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inﬂuential in vaccination decisions.
5. Conclusion
Our study demonstrates that both low and high HPV knowledge
may be associated with lower rates of vaccination, with parents'
country and gender also being inﬂuential factors. It also demonstrates
that parental attitudes towards the HPV vaccine diﬀer by country and
knowledge. These ﬁndings can contribute to the way the vaccine is
promoted and/or administered in the future across diﬀerent countries.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.pmedr.2017.10.005.
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